{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:08:48Z","timestamp":1781712528511,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>The effect of body fat deposition on the kidney has received increasing attention. The Chinese visceral adiposity index (CVAI) is an important indicator of recent research. The purpose of this study was to explore the predictive value of CVAI and other organ obesity indicators in predicting CKD in Chinese residents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cross-sectional study of 5355 subjects was performed. First, the study utilized locally estimated scatterplot smoothing to describe the dose\u2013response relationship between the estimated glomerular filtration rate (eGFR) and CVAI. The L1-penalized least absolute shrinkage and selection operator (LASSO) regression algorithm was used for covariation screening, and the correlation between CVAI and eGFR was quantified using multiple logistic regression. At the same time, the diagnostic efficiency of CVAI and other obesity indicators was evaluated by ROC curve analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CVAI and eGFR were negatively correlated. Using group one as the control, an odds ratio (OR) was calculated to quantify CVAI quartiles (ORs of Q2, Q3, and Q4 were 2.21, 2.99, and 4.42, respectively; <jats:italic>P<\/jats:italic> for trend &lt;\u20090.001). CVAI had the maximum area under the ROC curve compared with other obesity indicators, especially in the female population (AUC: 0.74, 95% <jats:italic>CI<\/jats:italic>: 0.71\u20130.76).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>CVAI is closely linked to renal function decline and has certain reference value for the screening of CKD patients, particularly in women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01783-6","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T10:02:50Z","timestamp":1677924170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A novel clinical diagnostic marker predicting the relationship between visceral adiposity and renal function evaluated by estimated glomerular filtration rate (eGFR) in the Chinese physical examination population"],"prefix":"10.1186","volume":"22","author":[{"given":"Yanping","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengte","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyou","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.ajkd.2019.05.032","volume":"76","author":"C Yang","year":"2020","unstructured":"Yang C, Wang H, Zhao X, Matsushita K, Coresh J, Zhang L, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76:258\u201364.","journal-title":"Am J Kidney Dis"},{"key":"1783_CR2","doi-asserted-by":"crossref","unstructured":"Bikbov B, Purcell CA, Levey AS , et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet. 2020;395(10225):709\u201333.","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"1783_CR3","doi-asserted-by":"crossref","unstructured":"Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl. 2005;(94):S63\u2013S67.","DOI":"10.1111\/j.1523-1755.2005.09416.x"},{"key":"1783_CR4","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. Jama. 2007;298:2038\u201347.","journal-title":"Jama"},{"key":"1783_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.ki.5002586","volume":"73","author":"Y Wang","year":"2008","unstructured":"Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73:19\u201333.","journal-title":"Kidney Int"},{"key":"1783_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0272-6386(01)80120-7","volume":"37","author":"F Bonnet","year":"2001","unstructured":"Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthez\u00e8ne F, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis. 2001;37:720\u20137.","journal-title":"Am J Kidney Dis"},{"key":"1783_CR7","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1681\/ASN.2017080850","volume":"28","author":"PF Mount","year":"2017","unstructured":"Mount PF, Juncos LA. Obesity-related CKD: when kidneys get the munchies. J Am Soc Nephrol. 2017;28:3429\u201332.","journal-title":"J Am Soc Nephrol"},{"key":"1783_CR8","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/CIR.0b013e31821c7c64","volume":"123","author":"PB Balagopal","year":"2011","unstructured":"Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, et al. Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation. 2011;123:2749\u201369.","journal-title":"Circulation"},{"key":"1783_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0899-9007(00)00471-8","volume":"17","author":"DC Frankenfield","year":"2001","unstructured":"Frankenfield DC, Rowe WA, Cooney RN, Smith JS, Becker D. Limits of body mass index to detect obesity and predict body composition. Nutrition. 2001;17:26\u201330.","journal-title":"Nutrition"},{"key":"1783_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/0002-9149(94)90676-9","volume":"73","author":"MC Pouliot","year":"1994","unstructured":"Pouliot MC, Despr\u00e9s JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460\u20138.","journal-title":"Am J Cardiol"},{"key":"1783_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.7326\/0003-4819-144-9-200605020-00020","volume":"144","author":"ML Thorp","year":"2006","unstructured":"Thorp ML. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:700\u20131 author reply 701-702.","journal-title":"Ann Intern Med"},{"key":"1783_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","volume":"7","author":"RV Shah","year":"2014","unstructured":"Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study. JACC Cardiovasc Imaging. 2014;7:1221\u201335.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1783_CR13","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1161\/ATVBAHA.114.303036","volume":"34","author":"H Wang","year":"2014","unstructured":"Wang H, Chen YE, Eitzman DT. Imaging body fat: techniques and cardiometabolic implications. Arterioscler Thromb Vasc Biol. 2014;34:2217\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1783_CR14","doi-asserted-by":"publisher","first-page":"20151024","DOI":"10.1259\/bjr.20151024","volume":"89","author":"PM Graffy","year":"2016","unstructured":"Graffy PM, Pickhardt PJ. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol. 2016;89:20151024.","journal-title":"Br J Radiol"},{"key":"1783_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33:920\u20132.","journal-title":"Diabetes Care"},{"key":"1783_CR16","first-page":"489","volume":"12","author":"X Xu","year":"2016","unstructured":"Xu X, Zhao Y, Zhao Z, Zhu S, Liu X, Zhou C, et al. Correlation of visceral adiposity index with chronic kidney disease in the People's Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity. Ther Clin Risk Manag. 2016;12:489\u201394.","journal-title":"Ther Clin Risk Manag"},{"key":"1783_CR17","doi-asserted-by":"publisher","first-page":"38214","DOI":"10.1038\/srep38214","volume":"6","author":"MF Xia","year":"2016","unstructured":"Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214.","journal-title":"Sci Rep"},{"key":"1783_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1753-0407.12108","volume":"6","author":"Y Bi","year":"2014","unstructured":"Bi Y, Lu J, Wang W, Mu Y, Zhao J, Liu C, et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes. 2014;6:147\u201357.","journal-title":"J Diabetes"},{"key":"1783_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/psp4.12695","volume":"10","author":"R Ramaswamy","year":"2021","unstructured":"Ramaswamy R, Wee SN, George K, Ghosh A, Sarkar J, Burghaus R, et al. CKD subpopulations defined by risk-factors: a longitudinal analysis of electronic health records. CPT Pharmacometrics Syst Pharmacol. 2021;10:1343\u201356.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1783_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2215\/CJN.10650620","volume":"16","author":"O Oluwo","year":"2021","unstructured":"Oluwo O, Scialla JJ. Uric acid and CKD progression matures with lessons for CKD risk factor discovery. Clin J Am Soc Nephrol. 2021;16:476\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1783_CR21","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","volume":"91","author":"C Garofalo","year":"2017","unstructured":"Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91:1224\u201335.","journal-title":"Kidney Int"},{"key":"1783_CR22","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/ndt\/gfn053","volume":"23","author":"D Mafra","year":"2008","unstructured":"Mafra D, Guebre-Egziabher F, Fouque D. Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant. 2008;23:2461\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"1783_CR23","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.jacc.2010.11.058","volume":"57","author":"T Coutinho","year":"2011","unstructured":"Coutinho T, Goel K, Corr\u00eaa de S\u00e1 D, Kragelund C, Kanaya AM, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. 2011;57:1877\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"1783_CR24","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/ndt\/gfm790","volume":"23","author":"RP Obermayr","year":"2008","unstructured":"Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, et al. Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant. 2008;23:1265\u201373.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"1783_CR25","first-page":"151","volume":"6","author":"NB Ruderman","year":"1982","unstructured":"Ruderman NB, Berchtold P, Schneider S. Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes (Lond). 1982;6(Suppl 1):151\u20137.","journal-title":"Int J Obes (Lond)"},{"key":"1783_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/07315724.2015.1046195","volume":"35","author":"A Mottaghi","year":"2016","unstructured":"Mottaghi A, Mirmiran P, Delshad H, Azizi F. Effect of different obesity phenotypes on incidence of chronic kidney disease in Tehranian adults. J Am Coll Nutr. 2016;35:587\u201396.","journal-title":"J Am Coll Nutr"},{"key":"1783_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-020-01095-4","volume":"19","author":"H Wan","year":"2020","unstructured":"Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19:118.","journal-title":"Cardiovasc Diabetol"},{"key":"1783_CR28","doi-asserted-by":"publisher","first-page":"13784","DOI":"10.1038\/s41598-017-14251-w","volume":"7","author":"J Wu","year":"2017","unstructured":"Wu J, Gong L, Li Q, Hu J, Zhang S, Wang Y, et al. A novel visceral adiposity index for prediction of type 2 diabetes and pre-diabetes in Chinese adults: a 5-year prospective study. Sci Rep. 2017;7:13784.","journal-title":"Sci Rep"},{"key":"1783_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1017\/S0007114520004298","volume":"126","author":"M Han","year":"2021","unstructured":"Han M, Qie R, Li Q, Liu L, Huang S, Wu X, et al. Chinese visceral adiposity index, a novel indicator of visceral obesity for assessing the risk of incident hypertension in a prospective cohort study. Br J Nutr. 2021;126:612\u201320.","journal-title":"Br J Nutr"},{"key":"1783_CR30","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jacc.2019.06.077","volume":"74","author":"ES Lau","year":"2019","unstructured":"Lau ES, Paniagua SM, Guseh JS, Bhambhani V, Zanni MV, Courchesne P, et al. Sex differences in circulating biomarkers of cardiovascular disease. J Am Coll Cardiol. 2019;74:1543\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"1783_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.116.023005","volume":"135","author":"J Lew","year":"2017","unstructured":"Lew J, Sanghavi M, Ayers CR, McGuire DK, Omland T, Atzler D, et al. Sex-based differences in cardiometabolic biomarkers. Circulation. 2017;135:544\u201355.","journal-title":"Circulation"},{"key":"1783_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/13697137.2012.707385","volume":"15","author":"SR Davis","year":"2012","unstructured":"Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, et al. Understanding weight gain at menopause. Climacteric. 2012;15:419\u201329.","journal-title":"Climacteric"},{"key":"1783_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/met.2017.0128","volume":"16","author":"R de Mutsert","year":"2018","unstructured":"de Mutsert R, Gast K, Widya R, de Koning E, Jazet I, Lamb H, et al. Associations of abdominal subcutaneous and visceral fat with insulin resistance and secretion differ between men and women: the Netherlands epidemiology of obesity study. Metab Syndr Relat Disord. 2018;16:54\u201363.","journal-title":"Metab Syndr Relat Disord"},{"key":"1783_CR34","first-page":"89","volume":"17","author":"H Zhang","year":"2014","unstructured":"Zhang H, Sairam MR. Sex hormone imbalances and adipose tissue dysfunction impacting on metabolic syndrome; a paradigm for the discovery of novel adipokines. Horm Mol Biol Clin Invest. 2014;17:89\u201397.","journal-title":"Horm Mol Biol Clin Invest"},{"key":"1783_CR35","first-page":"636","volume":"5","author":"C Mart\u00ednez-Garc\u00eda","year":"2012","unstructured":"Mart\u00ednez-Garc\u00eda C, Izquierdo A, Velagapudi V, Vivas Y, Velasco I, Campbell M, et al. Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech. 2012;5:636\u201348.","journal-title":"Dis Model Mech"},{"key":"1783_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrneph.2017.157","volume":"14","author":"Q Zhu","year":"2018","unstructured":"Zhu Q, Scherer PE. Immunologic and endocrine functions of adipose tissue: implications for kidney disease. Nat Rev Nephrol. 2018;14:105\u201320.","journal-title":"Nat Rev Nephrol"},{"key":"1783_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/etm.2021.9969","volume":"21","author":"D Miricescu","year":"2021","unstructured":"Miricescu D, Balan DG, Tulin A, Stiru O, Vacaroiu IA, Mihai DA, et al. Impact of adipose tissue in chronic kidney disease development (review). Exp Ther Med. 2021;21:539.","journal-title":"Exp Ther Med"},{"key":"1783_CR38","doi-asserted-by":"crossref","unstructured":"Czaja-Stolc S, Potrykus M, Stankiewicz M, Kaska \u0141, Ma\u0142gorzewicz S. Pro-inflammatory profile of Adipokines in obesity contributes to pathogenesis, nutritional disorders, and cardiovascular risk in chronic kidney disease. Nutrients. 2022;14(7):1457.","DOI":"10.3390\/nu14071457"},{"key":"1783_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1573399810602040367","volume":"2","author":"O Hamdy","year":"2006","unstructured":"Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367\u201373.","journal-title":"Curr Diabetes Rev"},{"key":"1783_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5005\/japi-11001-0110","volume":"70","author":"M Aggarwal","year":"2022","unstructured":"Aggarwal M, Verma G, Wahid A, Mathew S, Roat A. Visceral fat volume is a better predictor of insulin resistance than abdominal wall fat index in patients with prediabetes and type 2 diabetes mellitus. J Assoc Physicians India. 2022;70:11\u20132.","journal-title":"J Assoc Physicians India"},{"key":"1783_CR41","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311:F1087\u2013f1108.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1783_CR42","doi-asserted-by":"crossref","unstructured":"Korczynska J, Czumaj A, Chmielewski M, Swierczynski J, Sledzinski T. The causes and potential injurious effects of elevated serum leptin levels in chronic kidney disease patients. Int J Mol Sci. 2021;22(9):4685.","DOI":"10.3390\/ijms22094685"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01783-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T10:03:30Z","timestamp":1677924210000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01783-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01783-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (ethics number 2021\u20130479). Written informed consent was obtained from all patients. The research was conducted ethically by the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}